Friend or foe—The Pfizer‐BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis

Friend or foe—The Pfizer‐BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis

Abstract We described a rare case of vaccine‐induced acalculous cholecystitis (ACC). A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and labo...

Full description

Bibliographic Details
Main Authors: Bianca Maria Wahlen, Ruben Peralta, Hassan Al‐Thani, Ayman El‐Menyar
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Clinical Case Reports
Subjects:
acalculous cholecystitis
adverse event
booster
COVID‐19 vaccination
Online Access:https://doi.org/10.1002/ccr3.6078

Similar Items

Similar Items